Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 2Other 1Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1Overweight 1Obesity 1Breast Neoplasms 1

Interventions

angiotensin I (1-7) 3Leuprolide 2Hydrocortisone 2Bariatric Surgery 2methylnaltrexone 1lorcaserin 1apraglutide 1Vitamin E 1Vaccinium myrtillus extract 1Therapeutics 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Quality of Life 1Practice Guidelines as Topic 1Ovidrel 1Nicotine 1Monitoring, Physiologic 1Midazolam 1Losartan 1Lansoprazole 1Holistic Health 1High-Energy Shock Waves 1Furosemide 1Fibroblast Growth Factor 7 1Exercise 1Diet, Vegetarian 1Diet, Vegan 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Biopsy, Needle × Other × Clear all
NCT04291950 2022-12-20

Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women

University of Arizona

Withdrawn
BreastOther

Breast Neoplasms, Obesity, Overweight, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡